CorQuest MedTech
La probabilité de faillite calculée de CorQuest MedTech sur 12 mois est de 0,4% (très faible). L'entreprise est active depuis 2019 et le Moniteur belge ne contient aucun signal d'insolvabilité ou d'avertissement. Aucun chiffre de comptes annuels traité n'est disponible ; cette conclusion repose uniquement sur les données du registre et du Moniteur belge.
| Active | 6 ans |
| Direction | 5 |
| Sites | 1 |
| Publications | 16 |
Estimation statistique fondée sur des sources publiques — pas un conseil de crédit ni une constatation. Comment calculons-nous cela ?
| Exercice | Type | Dépôt | Référence |
|---|---|---|---|
| 31-12-2024 | volledig | 31-08-2025 | 2025-00472220 |
| 31-12-2023 | volledig | 31-07-2024 | 2024-00321215 |
| 31-12-2022 | volledig | 29-06-2023 | 2023-00197673 |
| 31-12-2021 | volledig | 09-08-2022 | 2022-20294586 |
| 31-12-2020 | volledig | 05-10-2021 | 2021-71000392 |
-
Actif01-10-2024 → auj.
-
Actif01-10-2024 → auj.
-
Merlot ManagementPersonne moraleAdministrateur· repr. perm.: Olivier DECUYPEREActe Moniteur 24378681 (20-03-2024)Actif20-03-2024 → auj.
-
Actif17-12-2021 → auj.
2 événements
- 20-03-2024 Mandat renouvelé· Administrateur
- 17-12-2021 Mandat renouvelé· Administrateur
-
Actif17-12-2021 → auj.
2 événements
- 20-03-2024 Mandat renouvelé· Administrateur
- 17-12-2021 Mandat renouvelé· Administrateur
Anciens dirigeants (1)
-
Ancien17-12-2021 → 20-03-2024
2 événements
- 20-03-2024 Démission· Administrateur
- 17-12-2021 Nommé· Administrateur
| NACE primaire | 26600 |
| Forme juridique | SRL(610) |
| Date de constitution | 30-08-2019 |
| Status | Actif |
| Code postal | 5020 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active — pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 25386B0152/00N000 | Wallonie | 4,0 ha | 1 · 1,2 ha | 34,9 m · 2 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise — publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
09-03-2026 Transfert du siège social vers Temploux
- Rue Lieutenant-Colonel Maniette 4 5020 Temploux
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Rue Lieutenant-Colonel Maniette 4\n5020 Temploux",
"city": "Temploux",
"region": "waals_gewest",
"street": "Rue Lieutenant-Colonel Maniette",
"country": "BE",
"postcode": "5020",
"box_number": null,
"street_number": "4",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2026-02-20",
"evidence_quote": "En date du 20 f\u00E9vrier 2026, les administrateurs agissant en qualit\u00E9 d\u0027organe d\u0027administration ont d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 avec effet imm\u00E9diat \u00E0 l\u0027adresse suivante:",
"region_changed": false,
"is_statute_change": true,
"nationality_change": true,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2026-03-09",
"filing_date": "2026-02-20",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": "2026-02-20",
"unanimous": true
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Calomme",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [
"Mod DOC 19.01"
]
}01-10-2024 2 administrateurs nommés
- Séverine de Sadeleer — Bestuurder
- Sandra Spiritelli — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "S\u00E9verine de Sadeleer",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer deux nouveaux administrateurs pour une dur\u00E9e de 6 ans et \u00E0 titre gratuit, et appelle \u00E0 ces fonctions: -Madame S\u00E9verine de Sadeleer"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sandra Spiritelli",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer deux nouveaux administrateurs pour une dur\u00E9e de 6 ans et \u00E0 titre gratuit, et appelle \u00E0 ces fonctions: -Madame Sandra Spiritelli."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}01-10-2024 Opération sur le capital ou les actions
Détails techniques
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}20-03-2024 Modification des statuts — traduction des statuts, coordination des statuts et refonte complète des statuts
Détails techniques
{
"notary": {
"name": "Bruno MICHAUX",
"firm_city": null,
"firm_name": null,
"office_city": "Etterbeek",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-03-20",
"filing_date": "2024-03-18",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS), CAPITAL, ACTIONS, DEMISSIONS, NOMINATIONS, DIVERS"
},
"decision": {
"body": "buitengewone_algemene_vergadering",
"act_date": "2024-03-08",
"unanimous": true
},
"statute_change": {
"kinds": [
"translation",
"coordination",
"full_restatement",
"object_change",
"capital_change",
"share_class_creation",
"warrant_exercise_capital_update",
"board_authorized_capital",
"governance_restructure",
"liquidation_preference_introduction",
"seat_region_change"
],
"scope": "full_restatement",
"trigger": "wvv_adaptation",
"language_after": "fr",
"language_before": "fr"
},
"bedrijfsrevisor": {
"firm_kbo": null,
"firm_name": "Be Audit",
"ibr_number": null,
"individual_name": "Ghislain DOCHEN"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full_after": "CorQuest MedTech",
"legal_form_after": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"name_full_before": "CorQuest MedTech",
"current_zetel_raw": "Chemin du Cyclotron 6, 1348 Ottignies-Louvain-la-Neuve",
"legal_form_before": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"special_mandates": [
{
"holder_kbo": "1005.438.949",
"holder_name": "Merlot Management",
"scope_categories": [
"kbo"
],
"with_substitution": true
}
],
"articles_modified": [
{
"summary": "The assembly decided to waive the requirement for a report on the price of issuance of new shares and the consequences of the operation on shareholders\u0027 rights.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:121 \u00A71 et \u00A72"
},
{
"summary": "The assembly dispensed the President from reading the two reports required by this article regarding the creation of share classes.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:102"
},
{
"summary": "The assembly dispensed the President from reading the two reports required by this article regarding the issuance of anti-dilutive subscription rights.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:122"
},
{
"summary": "The assembly renounced the right of pre-emption if necessary.",
"new_text": null,
"change_kind": "amended",
"article_title": null,
"article_number": "5:130, \u00A72"
},
{
"summary": "The company adopts the form of a limited liability company and is named \u0027CorQuest MedTech\u0027.",
"new_text": null,
"change_kind": "restated",
"article_title": "DENOMINATION",
"article_number": "PREMIER"
},
{
"summary": "The registered office is established in the Wallonia region and can be transferred within the same linguistic region by a simple decision of the administration.",
"new_text": null,
"change_kind": "restated",
"article_title": "SIEGE",
"article_number": "DEUX"
},
{
"summary": "The company\u0027s object includes activities related to medical devices, particularly structural and vascular cardiac implants, supporting the development of medical projects, and obtaining CE marking for other devices.",
"new_text": null,
"change_kind": "restated",
"article_title": "OBJET",
"article_number": "TROIS"
},
{
"summary": "The company is constituted for an unlimited duration and can be dissolved by a decision of the general meeting deliberating as in matters of statute modification.",
"new_text": null,
"change_kind": "restated",
"article_title": "DUREE",
"article_number": "QUATRE"
},
{
"summary": "The initial capital is \u20AC1,000. Capital has been increased by \u20AC500,000 in December 2021 and \u20AC435,000 in March 2024 through cash contributions.",
"new_text": null,
"change_kind": "restated",
"article_title": "CAPITAUX PROPRES",
"article_number": "CINQ"
},
{
"summary": "Shareholders can make contributions of assets or industry to the company, subject to a decision of the general meeting of shareholders.",
"new_text": null,
"change_kind": "restated",
"article_title": "APPORTS ULTERIEURS",
"article_number": "SIX"
},
{
"summary": "The company can issue all titles not prohibited by law. Titles are nominative and numbered.",
"new_text": null,
"change_kind": "restated",
"article_title": "DES TITRES",
"article_number": "SEPT"
},
{
"summary": "The company has issued 43,866 shares, all fully paid, distributed in several classes (A1, A2, B). Each share confers the same rights, except as provided in the statutes and shareholder agreements.",
"new_text": null,
"change_kind": "restated",
"article_title": "DES ACTIONS",
"article_number": "HUIT"
},
{
"summary": "Titles are indivisible vis-\u00E0-vis the company. If there are multiple owners, the company can suspend the exercise of rights until a single owner is designated.",
"new_text": null,
"change_kind": "restated",
"article_title": "INDIVISIBILITE DES TITRES",
"article_number": "NEUF"
},
{
"summary": "Shares can be transferred between living persons or upon death without approval, subject to restrictions. Free transfers are allowed to a company controlled by the transferring shareholder under specific conditions.",
"new_text": null,
"change_kind": "restated",
"article_title": "CESSIONS D\u2019ACTIONS",
"article_number": "DIX"
},
{
"summary": "Transfers upon death between a natural person shareholder and their heirs are subject to the right of pre-emption but not to the right of succession or obligation of succession.",
"new_text": null,
"change_kind": "restated",
"article_title": "CESSIONS A CAUSE DE MORT",
"article_number": "ONZE"
},
{
"summary": "If a transfer would result in the transfer of at least 50% of the company\u0027s shares, preemptive shareholders have the right to demand the purchase of their shares. If a third-party candidate acquires all shares, selling shareholders have the right to demand the purchase of their shares.",
"new_text": null,
"change_kind": "restated",
"article_title": "DROIT DE SUITE ET OBLIGATION DE SUITE",
"article_number": "DOUZE"
},
{
"summary": "The company is administered by one or more administrators, natural or legal persons, appointed by the general meeting for a renewable term of six years.",
"new_text": null,
"change_kind": "restated",
"article_title": "ORGANE D\u2019ADMINISTRATION",
"article_number": "TREIZE"
},
{
"summary": "When the administration is collegial, the board of directors meets upon convocation of the president or an administrator, or whenever the interest of the company requires it.",
"new_text": null,
"change_kind": "restated",
"article_title": "R\u00C9UNIONS ET D\u00C9LIB\u00C9RATIONS DE L\u2019ORGANE D\u2019ADMINISTRATION COLL\u00C9GIAL",
"article_number": "QUATORZE"
},
{
"summary": "When the company is administered by several administrators, they form a collegial administration called the board of directors, which represents the company. When administered by a single administrator, they represent the company.",
"new_text": null,
"change_kind": "restated",
"article_title": "POUVOIRS DE L\u2019ORGANE D\u2019ADMINISTRATION - REPRESENTATION",
"article_number": "QUINZE"
},
{
"summary": "The administration can delegate daily management and representation of the company for this management to one or more of its members, who bear the title of administrator-delegate.",
"new_text": null,
"change_kind": "restated",
"article_title": "GESTION JOURNALI\u00C8RE",
"article_number": "SEIZE"
},
{
"summary": "As long as the company meets the criteria stated in article 1:24 of the Code of Companies and Associations, there is no need to appoint a commissioner, unless a contrary decision is made by the general meeting.",
"new_text": null,
"change_kind": "restated",
"article_title": "CONTR\u00D4LE",
"article_number": "DIX-SEPT"
},
{
"summary": "The general meeting of shareholders is composed of all shareholders who have the right to vote for themselves or by proxies, subject to legal and statutory prescriptions.",
"new_text": null,
"change_kind": "restated",
"article_title": "COMPOSITION ET POUVOIRS",
"article_number": "DIX-HUIT"
},
{
"summary": "An ordinary general meeting of shareholders is held every year on the first Monday of June at 18:00.",
"new_text": null,
"change_kind": "restated",
"article_title": "ASSEMBLEE ORDINAIRE",
"article_number": "DIX-NEUF"
},
{
"summary": "The assembly meets specially or extraordinarily whenever the interest of the company requires it or upon the request of shareholders representing one-tenth of the number of shares in circulation.",
"new_text": null,
"change_kind": "restated",
"article_title": "ASSEMBLEE EXTRAORDINAIRE",
"article_number": "VINGT"
},
{
"summary": "The general meetings of shareholders can be convened by the administration or the commissioner(s) and must be convened upon the request of shareholders representing one-tenth of the number of shares in circulation.",
"new_text": null,
"change_kind": "restated",
"article_title": "CONVOCATIONS",
"article_number": "VINGT ET UN"
},
{
"summary": "Any shareholder is admitted to the general meeting provided that they are registered in the register of shareholders.",
"new_text": null,
"change_kind": "restated",
"article_title": "ADMISSION \u00C0 L\u2019ASSEMBL\u00C9E",
"article_number": "VINGT-DEUX"
},
{
"summary": "Any owner of titles who is prevented can be represented at the general meeting by a proxy, shareholder or not, and this by means of a written proxy.",
"new_text": null,
"change_kind": "restated",
"article_title": "REPR\u00C9SENTATION AUX ASSEMBL\u00C9ES G\u00C9N\u00C9RALES",
"article_number": "VINGT-TROIS"
},
{
"summary": "Before participating in the assembly, shareholders or their proxies are required to sign the attendance list, which mentions the name, first name and address or denomination and seat of the shareholders and the number of shares they represent.",
"new_text": null,
"change_kind": "restated",
"article_title": "LISTE DES PR\u00C9SENCES ET BUREAU",
"article_number": "VINGT-QUATRE"
},
{
"summary": "The administration has the right to postpone, in the same session, by three weeks the annual general meeting called to pronounce on the approval of the annual accounts and any other extraordinary assembly.",
"new_text": null,
"change_kind": "restated",
"article_title": "PROROGATION DE L\u2019ASSEMBL\u00C9E",
"article_number": "VINGT-CINQ"
},
{
"summary": "No assembly can deliberate on a subject that is not announced on the agenda, unless all shareholders are present and they decide unanimously. The general meeting can validly deliberate whatever the number of shares represented.",
"new_text": null,
"change_kind": "restated",
"article_title": "D\u00C9LIB\u00C9RATIONS DE L\u2019ASSEMBL\u00C9E G\u00C9N\u00C9RALE",
"article_number": "VINGT-SIX"
},
{
"summary": "The minutes of the general meetings are signed by the members of the bureau and the shareholders who request it. These minutes are inserted in a special register.",
"new_text": null,
"change_kind": "restated",
"article_title": "PROC\u00C8S-VERBAUX DES ASSEMBL\u00C9ES G\u00C9N\u00C9RALES",
"article_number": "VINGT-SEPT"
},
{
"summary": "The fiscal year begins on January 1st and ends on December 31st of each year. At the end of each fiscal year, the administration draws up an inventory and establishes the annual accounts of the company.",
"new_text": null,
"change_kind": "restated",
"article_title": "ANNEE SOCIALE",
"article_number": "VINGT-HUIT"
},
{
"summary": "The general meeting has the power to decide on the allocation of the profit and the amount of distributions. No distribution can be decided if the net assets of the company are negative or would become negative as a result of such a distribution.",
"new_text": null,
"change_kind": "restated",
"article_title": "DISTRIBUTION",
"article_number": "VINGT-NEUF"
},
{
"summary": "The annual general meeting votes on the annual accounts. After their adoption, the assembly pronounces by a special vote on the discharge to be given to the administrators and the commissioner(s) if any.",
"new_text": null,
"change_kind": "restated",
"article_title": "VOTE DES COMPTES ANNUELS",
"article_number": "TRENTE"
},
{
"summary": "When the net assets of the company are at risk of becoming or have become negative, the administration convenes the general meeting within a maximum period of two months after the situation has been ascertained or should have been ascertained in accordance with legal provisions.",
"new_text": null,
"change_kind": "restated",
"article_title": "PROCEDURE DE SONNETTE D\u2019ALARME",
"article_number": "TRENTE ET UN"
},
{
"summary": "In the event of dissolution of the company, for whatever cause and at whatever time, the liquidation is carried out by the liquidator(s) appointed by the general meeting and, in the absence of such appointment, by the administrators in office at that time, acting as a liquidation committee.",
"new_text": null,
"change_kind": "restated",
"article_title": "LIQUIDATION",
"article_number": "TRENTE-DEUX"
},
{
"summary": "After the settlement of all debts, charges and liquidation expenses or the deposit of the sums necessary for this purpose, the net assets are first used to repay in cash or securities the amount paid off of the shares.",
"new_text": null,
"change_kind": "restated",
"article_title": "REPARTITION",
"article_number": "TRENTE-TROIS"
},
{
"summary": "The parties intend to comply entirely with the Code of Companies and Associations. Consequently, the provisions of this Code to which it would not be licit to derogate by the present statutes are deemed to be inscribed in the statutes and clauses contrary to the mandatory provisions of this Code are",
"new_text": null,
"change_kind": "restated",
"article_title": "DROIT COMMUN",
"article_number": "TRENTE-QUATRE"
},
{
"summary": "For the execution of the statutes, any shareholder domiciled abroad, any administrator, liquidator, makes an election of domicile at the seat where all communications, summonses, assignments, notifications can be made to them.",
"new_text": null,
"change_kind": "restated",
"article_title": "ELECTION DE DOMICILE",
"article_number": "TRENTE-CINQ"
},
{
"summary": "For all disputes between the company, its shareholders, administrators, commissioners and liquidators relating to the affairs of the company and the execution of the present statutes, exclusive jurisdiction is attributed to the courts of the seat, unless the company renounces it expressly.",
"new_text": null,
"change_kind": "restated",
"article_title": "COMPETENCE JUDICIAIRE",
"article_number": "TRENTE-SIX"
},
{
"summary": "The provisions of the present statutes apply subject to the provisions contained in any pact or any shareholder agreement, provided that these provisions are not contrary to the mandatory provisions of the Code of Companies and Associations.",
"new_text": null,
"change_kind": "restated",
"article_title": "PACTE OU CONVENTION D\u2019ACTIONNAIRES",
"article_number": "TRENTE-SEPT"
}
],
"governance_change": {
"organ_kind_after": "collegial",
"organ_kind_before": "collegial",
"admin_delegated_added": [
{
"name": "Olivier DECUYPERE",
"excluded_powers": []
}
],
"representation_rule_after": "twee_gezamenlijk",
"co_signature_threshold_eur": null,
"representation_rule_before": "twee_gezamenlijk"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Bruno MICHAUX",
"org_rep_person_name": null
},
"co_filed_documents": [
"expedition de l\u2019acte",
"statuts coordonn\u00E9es",
"rapports"
],
"shareholder_rights": {
"quorum_rules_changed": false,
"liquidation_preference_text": null,
"voorkeurrecht_rules_changed": true,
"aandelenoverdracht_restrictions_changed": true
},
"voorwerp_change_summary": "The object of the company was updated to include activities related to medical devices, particularly structural and vascular cardiac implants, supporting the development of medical projects, and obtaining CE marking for other devices.",
"capital_structure_change": {
"operations": [
"capital_increase_cash",
"share_class_creation",
"wvv_capital_release"
],
"split_ratio": null,
"shares_after": 43866,
"shares_before": 43866,
"capital_after_eur": null,
"capital_before_eur": null,
"share_classes_after": [
{
"count": 28000,
"label": "A1",
"rights_summary": "Same rights as other classes, except as provided in statutes and shareholder agreements.",
"voting_per_share": 1.0
},
{
"count": 7000,
"label": "A2",
"rights_summary": "Same rights as other classes, except as provided in statutes and shareholder agreements.",
"voting_per_share": 1.0
},
{
"count": 8866,
"label": "B",
"rights_summary": "Same rights as other classes, except as provided in statutes and shareholder agreements.",
"voting_per_share": 1.0
}
]
},
"coordinated_text_lineage": null
}20-03-2024 Publication au Moniteur belge — Divers
Détails techniques
{
"stage": null,
"notary": {
"name": "Bruno MICHAUX",
"firm_city": null,
"firm_name": null,
"office_city": "Etterbeek",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-03-20",
"filing_date": "2024-03-18",
"act_kind_objet": "STATUTS (TRADUCTION, COORDINATION, AUTRES"
},
"decision": {
"body": "algemene_vergadering",
"act_date": "2024-03-08",
"unanimous": true
},
"conversion": null,
"detected_kind": "other",
"report_waiver": {
"summary": "L\u0027assembl\u00E9e a d\u00E9cid\u00E9, \u00E0 l\u0027unanimit\u00E9, de renoncer \u00E0 l\u0027\u00E9tablissement du rapport de l\u0027organe d\u0027administration prescrit par l\u0027article 5:121 \u00A71 du Code des soci\u00E9t\u00E9s et des associations, justifiant le prix d\u0027\u00E9mission des nouvelles actions et d\u00E9crivant les cons\u00E9quences de l\u0027op\u00E9ration sur les droits patrimo",
"articles": [
"5:121 \u00A71",
"5:121 \u00A72",
"5:102",
"5:122",
"5:130 \u00A72"
]
},
"restructuring": {
"parties": [
{
"kbo": "0733.537.853",
"name": "CorQuest MedTech",
"role": "contributor",
"address": "Chemin du Cyclotron 6, 1348 Ottignies-Louvain-la-Neuve",
"is_foreign": false,
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": null,
"real_estate_included": false,
"patrimony_description": null,
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Bruno MICHAUX",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 CorQuest MedTech a pris une s\u00E9rie de d\u00E9cisions pour modifier ses statuts et son capital. Ces d\u00E9cisions incluent des apports en num\u00E9raire suppl\u00E9mentaires de 435.000 EUR, l\u0027\u00E9mission de nouvelles actions et de warrants, la cr\u00E9ation de classes d\u0027actions, et la d\u00E9mission et nomination d\u0027un administrateur.",
"co_filed_documents": [
"une exp\u00E9dition de l\u0027acte",
"des statuts coordonn\u00E9es",
"des rapports"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}20-03-2024 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2024-03-08",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
},
"signature_regime": "joint_two",
"special_mandates": [
{
"quote": "L\u2019assembl\u00E9e conf\u00E8re au notaire soussign\u00E9 tous pouvoirs pour l\u2019\u00E9tablissement des statuts coordonn\u00E9s et leur d\u00E9p\u00F4t au Greffe du Tribunal de l\u2019entreprise comp\u00E9tent.",
"holder_kbo": null,
"holder_name": "Notaire soussign\u00E9",
"scope_categories": [
"publication",
"filing"
],
"with_substitution": true
},
{
"quote": "Un pouvoir particulier est conf\u00E9r\u00E9 \u00E0 l\u2019organe d\u2019administration, avec pouvoir de substitution et pouvoir d\u2019agir chacun individuellement, \u00E0 l\u2019effet de faire ex\u00E9cuter toutes modifications n\u00E9cessaires de la soci\u00E9t\u00E9 au Registre des Personnes Morales comp\u00E9tent, \u00E0 l\u2019Administration de la Taxe sur la Valeur Ajout\u00E9e, si n\u00E9cessaire, et aupr\u00E8s de tout autre administration, ainsi qu\u2019\u00E0 la Banque-Carrefour des Entreprises.",
"holder_kbo": null,
"holder_name": "l\u2019organe d\u2019administration",
"scope_categories": [
"filing",
"tax",
"KBO"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}20-03-2024 Augmentation de capital de 435.000 €
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": null,
"delta_eur": 435000.0,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": null,
"n_new_shares": 3866,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 112.5
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 435000.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "warrant_issuance",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_conversion",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Bruno MICHAUX",
"firm_city": null,
"firm_name": null,
"office_city": "Etterbeek",
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-03-20",
"filing_date": "2024-03-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2024-03-08",
"unanimous": true,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "Be Audit",
"ibr_number": null,
"mission_type": "quasi_apport",
"individual_name": "Ghislain DOCHEN"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"expedition",
"statuts coordonn\u00E9es",
"rapports"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 28000,
"class_name": "A1",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 7000,
"class_name": "A2",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
},
{
"n_shares": 8866,
"class_name": "B",
"capital_share_eur": null,
"voting_rights_per_share": 1.0
}
]
}20-03-2024 1 administrateur nommé, 1 démissionnaire, 2 reconduits
- Olivier DECUYPERE — Bestuurder
- Olivier DECUYPERE — Bestuurder
- Arnaud van SCHEVENSTEEN — Bestuurder
- Didier DE CANNIÈRE — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Est ici intervenu, Monsieur Olivier DECUYPERE, pr\u00E9nomm\u00E9, qui d\u00E9clare d\u00E9missionner de son mandat d\u2019administrateur de la soci\u00E9t\u00E9 \u00E0 dater de ce jour.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": "1005.438.949",
"name": "Merlot Management",
"address": "1180 Bruxelles (Uccle), avenue Circulaire 152",
"country": "BE",
"legal_form": "SRL"
},
"statutory": null,
"compensated": false,
"effective_date": null,
"evidence_quote": "En remplacement de Monsieur Olivier DECUYPERE, l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer comme nouvel administrateur la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB Merlot Management \u00BB",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Arnaud van SCHEVENSTEEN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide que la dur\u00E9e du mandat d\u2019administrateur des deux autres administrateurs actuels de la soci\u00E9t\u00E9, \u00E0 savoir, Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, initialement nomm\u00E9s pour une dur\u00E9e illimit\u00E9e, sera modifi\u00E9e et d\u00E9sormais fix\u00E9e \u00E0 six (6) ans \u00E0 date",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_renew",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Didier DE CANNI\u00C8RE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide que la dur\u00E9e du mandat d\u2019administrateur des deux autres administrateurs actuels de la soci\u00E9t\u00E9, \u00E0 savoir, Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, initialement nomm\u00E9s pour une dur\u00E9e illimit\u00E9e, sera modifi\u00E9e et d\u00E9sormais fix\u00E9e \u00E0 six (6) ans \u00E0 date",
"decharge_status": null,
"mandate_duration": {
"kind": "n_years",
"value": "6"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale se prononcera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge \u00E0 donner \u00E0 l\u2019administrateur d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Arnaud van SCHEVENSTEEN",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale se prononcera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge \u00E0 donner \u00E0 l\u2019administrateur d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Didier DE CANNI\u00C8RE",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale se prononcera \u00E0 la prochaine assembl\u00E9e g\u00E9n\u00E9rale annuelle sur la d\u00E9charge \u00E0 donner \u00E0 l\u2019administrateur d\u00E9missionnaire pour l\u2019ex\u00E9cution de son mandat.",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": "Bruno MICHAUX",
"firm_city": null,
"firm_name": null,
"office_city": "Etterbeek",
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": "2024-03-20",
"filing_date": "2024-03-18",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "buitengewone_algemene_vergadering",
"date": "2024-03-08",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Bruno MICHAUX",
"org_rep_person_name": null,
"person_role_at_subject": "notaire"
},
"co_filed_documents": [
"exp\u00E9dition de l\u2019acte",
"statuts coordonn\u00E9es",
"rapports"
],
"corrected_publication_numac": null
}20-03-2024 Augmentation de capital de 435.000 €
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 435000.0,
"currency": "EUR",
"after_eur": null,
"delta_eur": 435000.0,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2024-03-08",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 des apports en num\u00E9raire suppl\u00E9mentaires d\u2019un montant de quatre cent trente-cinq mille euros (435.000,00 EUR) et d\u2019\u00E9mettre, en r\u00E9mun\u00E9ration de ces apports, trois mille huit cent soixante-six (3.866) nouvelles actions",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}20-03-2024 1 administrateur nommé, 1 démissionnaire, 2 reconduits
- Olivier DECUYPERE — Bestuurder
- Olivier DECUYPERE — Bestuurder
- Arnaud van SCHEVENSTEEN — Bestuurder
- Didier DE CANNIÈRE — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null
},
"effective_date": "2024-03-20",
"evidence_quote": "Est ici intervenu, Monsieur Olivier DECUYPERE, pr\u00E9nomm\u00E9, qui d\u00E9clare d\u00E9missionner de son mandat d\u2019administrateur de la soci\u00E9t\u00E9 \u00E0 dater de ce jour."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "1005438949",
"name": "Merlot Management",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2024-03-20",
"evidence_quote": "En remplacement de Monsieur Olivier DECUYPERE, l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer comme nouvel administrateur la soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e \u00AB Merlot Management \u00BB, ayant son si\u00E8ge \u00E0 1180 Bruxelles (Uccle), avenue Circulaire 152, inscrite au Registre des Personnes Morales de Bruxelles sous le"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Arnaud van SCHEVENSTEEN",
"address": null,
"birth_date": null
},
"effective_date": "2024-03-20",
"evidence_quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide que la dur\u00E9e du mandat d\u2019administrateur des deux autres administrateurs actuels de la soci\u00E9t\u00E9, \u00E0 savoir, Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, initialement nomm\u00E9s pour une dur\u00E9e illimit\u00E9e, sera modifi\u00E9e et d\u00E9sormais fix\u00E9e \u00E0 six (6) ans \u00E0 date"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Didier DE CANNI\u00C8RE",
"address": null,
"birth_date": null
},
"effective_date": "2024-03-20",
"evidence_quote": "l\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide que la dur\u00E9e du mandat d\u2019administrateur des deux autres administrateurs actuels de la soci\u00E9t\u00E9, \u00E0 savoir, Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, initialement nomm\u00E9s pour une dur\u00E9e illimit\u00E9e, sera modifi\u00E9e et d\u00E9sormais fix\u00E9e \u00E0 six (6) ans \u00E0 date"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}07-02-2024 Transfert du siège social de Beauvechain à Louvain-la-Neuve
- Rue de l'Etang 33, 1320 Beauvechain → Chemin du Cyclotron 6, 1348 Louvain-la-Neuve
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Louvain-la-Neuve",
"region": "Waals",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6"
},
"old_address": {
"city": "Beauvechain",
"region": "Waals",
"street": "Rue de l\u0027Etang",
"country": "BE",
"postcode": "1320",
"box_number": null,
"street_number": "33"
},
"effective_date": "2023-12-21",
"evidence_quote": "En date du 21 d\u00E9cembre 2023, les administrateurs agissant en qualit\u00E9 d\u0027organe d\u0027administration ont d\u00E9cid\u00E9, \u00E0 l\u0027unanimit\u00E9, de transf\u00E9rer le si\u00E8ge de la soci\u00E9t\u00E9 avec effet imm\u00E9diat \u00E0 l\u0027adresse suivante comme suit: CorQuest MedTech SRL c/o Centre d\u0027entreprise et d\u0027innovation de Louvain-la-Neuve SA Chemin du Cyclotron 6 1348 Louvain-la-Neuve"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}07-02-2024 Transfert du siège social vers Louvain-la-Neuve
- Chemin du Cyclotron 6 1348 Louvain-la-Neuve
Détails techniques
{
"events": [
{
"kind": "zetel_transfer_cross_border_in",
"seat_type": "siege_administratif",
"new_address": {
"raw": "Chemin du Cyclotron 6\n1348 Louvain-la-Neuve",
"city": "Louvain-la-Neuve",
"region": "waals_gewest",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6",
"locality_suffix": null
},
"old_address": null,
"effective_date": "2023-12-21",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": true,
"old_address_source": "inferred",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "immediate",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": null,
"filing_date": "2024-01-25",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-12-21",
"unanimous": true
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "org",
"org_kbo": "0759.412.703",
"org_name": "SRL COMPAGNIE FIDUCIAIRE ET DE GESTION",
"person_name": null,
"org_rep_person_name": "Nathalie Calomme",
"person_role_at_subject": null
},
"co_filed_documents": [
"Bijlagen bij het Belgisch Staatsbla",
"Annexes du Moniteur belge"
]
}23-12-2021 Modification des statuts
Détails techniques
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2021-12-17",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
},
"signature_regime": null,
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}23-12-2021 Augmentation de capital de 500.000 €
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"amount": 500000,
"currency": "EUR",
"after_eur": null,
"delta_eur": 500000,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2021-12-17",
"evidence_quote": "L\u2019assembl\u00E9e d\u00E9cide de proc\u00E9der \u00E0 des apports en esp\u00E8ces suppl\u00E9mentaires d\u2019un montant de cinq cent mille euros (500.000,00 EUR) et d\u2019\u00E9mettre, en r\u00E9mun\u00E9ration de ces apports, cinq mille (5.000) nouvelles actions",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}23-12-2021 1 administrateur nommé, 2 reconduits
- Olivier DECUYPERE — Bestuurder
- Arnaud van SCHEVENSTEEN — Bestuurder
- Didier DE CANNIÈRE — Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Olivier DECUYPERE",
"address": null,
"birth_date": null
},
"effective_date": "2021-12-17",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale d\u00E9cide de nommer un troisi\u00E8me administrateur (non statutaire) pour une dur\u00E9e de six (6) ans, \u00E0 dater de ce jour, \u00E0 savoir : Monsieur Olivier DECUYPERE, pr\u00E9nomm\u00E9, domicili\u00E9 \u00E0 Uccle (1180 Bruxelles), avenue Circulaire 152 , ici pr\u00E9sent et qui accepte."
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Arnaud van SCHEVENSTEEN",
"address": null,
"birth_date": null
},
"effective_date": "2021-12-17",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale confirme, pour autant que de besoin, les fonctions d\u2019administrateur de Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, et constate que plusieurs administrateurs ayant \u00E9t\u00E9 nomm\u00E9s, les trois administrateurs forment un organe d\u2019 administration coll\u00E9gial d\u00E9nomm\u00E9 "
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Didier DE CANNI\u00C8RE",
"address": null,
"birth_date": null
},
"effective_date": "2021-12-17",
"evidence_quote": "L\u2019assembl\u00E9e g\u00E9n\u00E9rale confirme, pour autant que de besoin, les fonctions d\u2019administrateur de Messieurs Arnaud van SCHEVENSTEEN et Didier DE CANNI\u00C8RE, pr\u00E9nomm\u00E9s, et constate que plusieurs administrateurs ayant \u00E9t\u00E9 nomm\u00E9s, les trois administrateurs forment un organe d\u2019 administration coll\u00E9gial d\u00E9nomm\u00E9 "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CORQUEST MEDTECH",
"legal_form": "SRL"
}
}03-09-2019 Constitution d'une société (SRL)
Détails techniques
{
"kind": "oprichting",
"seat": "1320 Beauvechain",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1971-10-04",
"name": "van SCHEVENSTEEN Arnaud Pierre Jean-Claude Marie",
"niss": null,
"address": "1320 Beauvechain (Nodebais), Rue de l\u0027Etang, 33"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 500,
"holder_person_name": "van SCHEVENSTEEN Arnaud Pierre Jean-Claude Marie",
"is_subscriber_only": false,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 500,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1959-04-19",
"name": "DE CANNI\u00C8RE Didier Pierre Andr\u00E9 Raoul",
"niss": null,
"address": "1640 Rhode-Saint-Gen\u00E8se, Dr\u00E8ve de l\u0027Ermite, 21"
},
"share_class": "Ordinary",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 500,
"holder_person_name": "DE CANNI\u00C8RE Didier Pierre Andr\u00E9 Raoul",
"is_subscriber_only": false,
"n_shares_subscribed": 50,
"amount_subscribed_eur": 500,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 1000,
"subject_company": {
"kbo": "0733.537.853",
"name_full": "CorQuest MedTech",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2019-08-28",
"post_incorporation_mandates": []
}Générez une note structurée et factuelle à partir de tous les signaux de ce dossier : risque, santé financière, structure de propriété, mandats et comparaison sectorielle.
| Dénomination légaleFR | CorQuest MedTech |